Jellyfish deaths spark research call
23 April, 2002 by Iain ScottThe recent deaths of two tourists thought to have been stung by tiny, previously unknown species of jellyfish off tropical Queensland beaches has sparked a call for extensive research funding.
GroPep revises forecast, now predicts loss
23 April, 2002 by Tanya HollisDrug discovery group GroPep (ASX: GRO) has forecast a $4 million loss this year despite predicting profits of $1.9 million for 2001-02 just two months ago.
Polartechnics wins design awards
23 April, 2002 by Daniella GoldbergSydney-based biotechnology company Polartechnics has came out on top with two design awards for its cervical cancer detection device, TruScan.
Cryosite's IPO closes oversubscribed
23 April, 2002 by Daniella GoldbergCryogenic storage of umbilical cord blood has been given the thumbs up by Australian investors, with today's announcement that Cryosite's IPO closed early and oversubscribed.
Never the twain? GM and organic farming go head to head
22 April, 2002 by Melissa TrudingerThe co-existence of genetically modified (GM) and organic farming was hotly debated at a meeting hosted by the Life Sciences Network last week.
NZ turns to microbes to fight methane levels
22 April, 2002 by Daniella GoldbergNew Zealand's pastoral sector is planning to pool its resources in a new bid to reduce the amount of methane gas emissions from the country's livestock.
Greenpeace to begin Australian anti-GE campaign
19 April, 2002 by Daniella GoldbergGreenpeace has hired its first local team to campaign against genetic engineering in Australia.
Gradipore to appoint CEO, independent chair
19 April, 2002 by Iain ScottGradipore is on the hunt for a global CEO and an independent chair in a bid to become a "multi-billion dollar organisation," executive chairman John Manusu said today.
Norwood Abbey's laser awaits FDA approval
18 April, 2002 by Tanya HollisNorwood Abbey today announced it was awaiting FDA approval for its newly patented laser drug delivery system for anaesthesia.
ResMed has global Objective
17 April, 2002 by Daniella GoldbergResMed, Australia's largest manufacturer and exporter of medical respiratory devices, has renewed its license to Objective Corporation's knowledge and process management solution.
Milk money for Aust dairy industry
17 April, 2002 by Tanya HollisLong-term dairy research projects with the potential to contribute to the Victorian economy will have a chance at financial backing worth $1.25 million over five years.
Biohubs need to establish good corporate governance
17 April, 2002 by Daniella GoldbergEstablishing corporate governance from the outset is vital for a company to succeed. The process for companies managing research biohubs, however, has become a lot more complex and time-consuming, according to Adam Liberman, a partner at law firm Freehills.
Gradipore prepares technology for dialysis work
17 April, 2002 by Daniella GoldbergSydney-based biotech Gradipore is adapting its Gradiflow technology to help treat patients with kidney failure.
GRDC will put rice genome to work
16 April, 2002 by Melissa TrudingerAustralia's Grains Research and Development Corporation (GRDC) is in line to become one of the first commercial organisations licensed to use Syngenta's rice genome sequence.
Growth Industry
15 April, 2002 by Melissa TrudingerPlant genetics is a driving force in agricultural biotech in Australia, affecting the commercial crop industries, horticulture, forestry and viticulture. Even livestock industries have plant biotechnology programs to develop improved pasture crops.
